Related Experiment Video
Updated: Jul 14, 2026

Toeprinting Analysis of Translation Initiation Complex Formation on Mammalian mRNAs
Published on: May 10, 2018
Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent
Benoit Bilanges1, Rhoda Argonza-Barrett, Marina Kolesnichenko
1Cancer Research Institute, University of California, San Francisco, California, USA.
Abstract:
The tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 regulate protein translation by inhibiting the serine/threonine kinase mTORC1 (for mammalian target of rapamycin complex 1). However, how TSC1 and TSC2 control overall protein synthesis and the translation of specific mRNAs in response to different mitogenic and nutritional stimuli is largely unknown. We show here that serum withdrawal inhibits mTORC1 signaling, causes disassembly of translation initiation complexes, and causes mRNA redistribution from polysomes to subpolysomes in wild-type mouse embryo fibroblasts (MEFs). In contrast, these responses are defective in Tsc1(-/-) or Tsc2(-/-) MEFs. Microarray analysis of polysome- and subpolysome-associated mRNAs uncovered specific mRNAs that are translationally regulated by serum, 90% of which are TSC1 and TSC2 dependent. Surprisingly, the mTORC1 inhibitor, rapamycin, abolished mTORC1 activity but only affected approximately 40% of the serum-regulated mRNAs. Serum-dependent signaling through mTORC1 and polysome redistribution of global and individual mRNAs were restored upon re-expression of TSC1 and TSC2. Serum-responsive mRNAs that are sensitive to inhibition by rapamycin are highly enriched for terminal oligopyrimidine and for very short 5' and 3' untranslated regions. These data demonstrate that the TSC1/TSC2 complex regulates protein translation through mainly mTORC1-dependent mechanisms and implicates a discrete profile of deregulated mRNA translation in tuberous sclerosis pathology.
Insights
The tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 regulate protein translation via mTORC1 signaling. Loss of TSC1/TSC2 impairs mRNA translation control, impacting specific mRNAs crucial for tuberous sclerosis pathology.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 are known regulators of the mTORC1 pathway.
- The precise mechanisms by which TSC1/TSC2 control global protein synthesis and specific mRNA translation under varying stimuli remain unclear.
Purpose of the Study:
- To investigate how TSC1 and TSC2 regulate protein translation in response to serum withdrawal.
- To identify specific mRNAs translationally controlled by TSC1/TSC2 and the mTORC1 pathway.
Main Methods:
- Utilized wild-type and Tsc1/Tsc2-deficient mouse embryo fibroblasts (MEFs).
- Analyzed mTORC1 signaling, translation initiation complex assembly, and mRNA distribution between polysomes and subpolysomes.
- Performed microarray analysis on polysome- and subpolysome-associated mRNAs.
- Investigated the effect of the mTORC1 inhibitor rapamycin.
Main Results:
- Serum withdrawal inhibited mTORC1 signaling and altered translation complexes in wild-type MEFs, but not in Tsc1/Tsc2-deficient MEFs.
- 90% of serum-regulated mRNAs were dependent on TSC1 and TSC2 for their translational control.
- Rapamycin affected only 40% of serum-regulated mRNAs, indicating TSC1/TSC2-dependent regulation beyond mTORC1 inhibition.
- Re-expression of TSC1/TSC2 restored serum-dependent signaling and mRNA redistribution.
- Rapamycin-sensitive, serum-responsive mRNAs were enriched for specific untranslated regions (UTRs).
Conclusions:
- The TSC1/TSC2 complex is a major regulator of protein translation, primarily through mTORC1-dependent mechanisms.
- Specific mRNA translation profiles are deregulated in TSC, implicating altered translation in the pathology.
- TSC1/TSC2 control mRNA translation in response to mitogenic and nutritional cues, with implications for tuberous sclerosis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Regulation of Expression at Multiple Steps
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

